WHO list of priority medical devices for management of cardiovascular diseases and diabetes PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download WHO list of priority medical devices for management of cardiovascular diseases and diabetes PDF full book. Access full book title WHO list of priority medical devices for management of cardiovascular diseases and diabetes by . Download full books in PDF and EPUB format.
Author: Publisher: World Health Organization ISBN: 9240027971 Category : Medical Languages : en Pages : 180
Book Description
The final goal of this publication is to guide on the selection of medical devices. This increases access to medical devices required to prevent, diagnose and treat cardiovascular diseases (including stroke) and diabetes, especially in low and middle resource settings. This publication is intended for Ministries of Health, public health planners, health technology managers, disease managers, researchers, policy-makers, funding and procurement agencies, and support and advocacy groups for patients suffering from cardiac diseases, stroke and diabetes. It serves to inform policy-makers and technical decision-makers on the selection of medical devices required for the package of benefits and interventions for a target population in the context of universal health coverage.
Author: World Health Organization Publisher: ISBN: 9789241565462 Category : Medical instruments and apparatus Languages : en Pages : 246
Book Description
This is the model list and clearing house of appropriate, basic, and priority medical devices based on the list of clinical interventions selected from clinical guidelines on prevention, screening, diagnosis, treatment, palliative care, monitoring, and end of life care. This publication addresses medical devices that can be used for the management of cancer and specifically describes medical devices for six types of cancer: breast, cervical, colorectal, leukemia, lung, and prostate. This book is intended for ministries of health, public health planners, health technology managers, disease management, researchers, policy makers, funding, and procurement agencies and support and advocacy groups for cancer patients.
Author: Publisher: World Health Organization ISBN: 9240027971 Category : Medical Languages : en Pages : 180
Book Description
The final goal of this publication is to guide on the selection of medical devices. This increases access to medical devices required to prevent, diagnose and treat cardiovascular diseases (including stroke) and diabetes, especially in low and middle resource settings. This publication is intended for Ministries of Health, public health planners, health technology managers, disease managers, researchers, policy-makers, funding and procurement agencies, and support and advocacy groups for patients suffering from cardiac diseases, stroke and diabetes. It serves to inform policy-makers and technical decision-makers on the selection of medical devices required for the package of benefits and interventions for a target population in the context of universal health coverage.
Author: World Health Organization Publisher: World Health Organization ISBN: 9241564040 Category : Medical Languages : en Pages : 147
Book Description
Background papers 1 to 9 published as technical documents. Available in separate records from WHO/HSS/EHT/DIM/10.1 to WHO/HSS/EHT/DIM/10.9
Author: Institute of Medicine Publisher: National Academies Press ISBN: 0309158060 Category : Medical Languages : en Pages : 442
Book Description
Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The Institute of Medicine (IOM) recommends implementing an integrated national strategy to promote rare diseases research and product development.
Author: Publisher: World Health Organization ISBN: 9240025278 Category : Medical Languages : en Pages : 126
Book Description
This framework document is a “how-to” guide for policy-makers and programme managers to effectively implement the CureAll pillars and enablers. It provides justification for action, posits priority interventions and proposes a monitoring framework. Key components needed to establish, scale up and sustain a well-functioning national childhood cancer programme are explained.The scope of this framework document is centrally defined by the programmes, services and policies that support children with cancer in the context of the health system. For the Initiative, children are defined as those aged 19 years or younger. Childhood cancer care requires cross-cutting strategies, such as workforce training, that often have overlap with broader child health and/or cancer control programmes. These synergies are highlighted and considered in scope for the Initiative and for an integrated response in childhood cancer control. The primary audience for this framework document are policy-makers, cancer control programme managers and hospital managers at the country level. Additional key stakeholders may also find the information in this guide beneficial, including clinicians, parent groups, civil society, academia and interested parties in the private sector. The primary audience for this framework document are policy-makers, cancer control programme managers and hospital managers at the country level. Additional key stakeholders may also find the information in this guide beneficial, including clinicians, parent groups, civil society, academia and interested parties in the private sector.
Author: Institute of Medicine Publisher: National Academies Press ISBN: 0309042860 Category : Medical Languages : en Pages : 241
Book Description
The very rapid pace of advances in biomedical research promises us a wide range of new drugs, medical devices, and clinical procedures. The extent to which these discoveries will benefit the public, however, depends in large part on the methods we choose for developing and testing them. Modern Methods of Clinical Investigation focuses on strategies for clinical evaluation and their role in uncovering the actual benefits and risks of medical innovation. Essays explore differences in our current systems for evaluating drugs, medical devices, and clinical procedures; health insurance databases as a tool for assessing treatment outcomes; the role of the medical profession, the Food and Drug Administration, and industry in stimulating the use of evaluative methods; and more. This book will be of special interest to policymakers, regulators, executives in the medical industry, clinical researchers, and physicians.
Author: World Health Organization Publisher: World Health Organization ISBN: 9240088504 Category : Medical Languages : en Pages : 108
Book Description
The survey results provide an understanding of the landscape of the inclusion of cancer care along the path to universal health coverage (UHC). This survey determines what countries included in their largest public- sector HBPs in terms of types of cancer, screening services, cancer treatments (with particular emphasis on cancer medicines), and palliative and survivorship care. The findings of the report strengthen the need for greater support for cancer-care planning and delivery, to continue progress towards UHC.
Author: National Academies of Sciences, Engineering, and Medicine Publisher: National Academies Press ISBN: 0309458021 Category : Medical Languages : en Pages : 127
Book Description
Though cancer was once considered to be a problem primarily in wealthy nations, low- and middle-income countries now bear a majority share of the global cancer burden, and cancer often surpasses the burden of infectious diseases in these countries. Effective low-cost cancer control options are available for some malignancies, with the World Health Organization estimating that these interventions could facilitate the prevention of approximately one-third of cancer deaths worldwide. Effective cancer treatment approaches are also available and can reduce the morbidity and mortality due to cancer in low-resource areas. But these interventions remain inaccessible for many people in the world, especially those residing in low-resource communities that are characterized by a lack of fundsâ€"on an individual or a societal basisâ€"to cover health infrastructure and care costs. As a result, worse outcomes for patients with cancer are more common in low- and middle-income countries compared with high-income countries. Few guidelines and strategies for cancer control consider the appropriateness and feasibility of interventions in low-resource settings, and this may undermine the effectiveness of care. Recognizing the challenges of providing cancer care in resource constrained settings, the National Academies of Sciences, Engineering, and Medicine developed a two- workshop series examining cancer care in low-resource communities, building on prior work of the National Academies. The first workshop, held in October 2015, focused on cancer prevention and early detection. The second workshop was held in November 2016, and focused on cancer treatment, palliative care, and survivorship care in low-resource areas. This publication summarizes the presentations and discussions of this workshop.
Author: 
Author: World Health Organization
Author: 
Author: World Health Organization
Author: World Health Organization
Author: Institute of Medicine
Author: 
Author: Institute of Medicine
Author: World Health Organization
Author: National Academies of Sciences, Engineering, and Medicine
Author: World Health Organization